Effectiveness of mRNA Booster Vaccine Against Coronavirus Disease 2019 Infection and Severe Outcomes Among Persons With and Without Immune Dysfunction: A Retrospective Cohort Study of National Electronic Medical Record Data in the United States.

Jing SunQulu ZhengAlfred J AnzaloneAlison G AbrahamAmy L OlexYifan ZhangJomol MathewNasia SafdarMelissa A HaendelDorry SegevJessica Yasmine IslamJasvinder A SinghRoslyn B MannonChristopher G ChuteRena C PatelGregory D Kirk

Published in: Open forum infectious diseases (2024)

Booster vaccines remain effective against severe COVID-19 BTI throughout the Delta- and Omicron-predominant periods, regardless of patients' immune status.

Keyphrases

coronavirus disease
end stage renal disease
ejection fraction
sars cov
randomized controlled trial
newly diagnosed
early onset
systematic review
peritoneal dialysis
prognostic factors
oxidative stress
big data
quality improvement
patient reported outcomes
binding protein
drug induced
artificial intelligence